Cost–benefit analysis of Canada’s Prison Needle Exchange Program for the prevention of hepatitis C and injection-related infections

Original research
par
Houdroge, Farah et al

Date de publication

2024

Géographie

Canada

Langue de la ressource

English

Texte disponible en version intégrale

Oui

Open Access / OK to Reproduce

Oui

Évalué par des pairs

Yes

L’objectif

We sought to assess the return on investment of existing Prison Needle Exchange Programs (PNEPs) in Canadian federal prisons and their expansion to all 43 institutions.

Constatations/points à retenir

Every dollar invested in the current PNEP or its expansion is estimated to save $2 in hepatitis C and injection-related infection treatment costs. This return on investment strongly supports ongoing maintenance and scale-up of the PNEP in Canada from an economic perspective.

La conception ou méthodologie de recherche

We developed a stochastic compartmental model that estimated hepatitis C and injection-related infections under different PNEP scenarios in Canadian federal prisons. We calculated the benefit–cost ratio as benefits from health care savings, divided by PNEP costs.

Mots clés

Injecting drugs
Harm reduction
Legal system/law enforcement
Policy/Regulatory
Social benefits
Social services